A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer
Clinical trial NCT03749083 · WITHDRAWN
Trial details
- NCT number
- NCT03749083
- Sponsor
- Massachusetts General Hospital
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-31
- Primary completion
- 2021-10-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.